Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells.

Warrier SR, Haridas N, Balasubramanian S, Jalisatgi A, Bhonde R, Dharmarajan A.

Cell Prolif. 2013 Jun;46(3):283-90. doi: 10.1111/cpr.12026.

PMID:
23692087
2.

Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways.

Hao H, Chen G, Liu J, Ti D, Zhao Y, Xu S, Fu X, Han W.

PLoS One. 2013;8(3):e58314. doi: 10.1371/journal.pone.0058314. Epub 2013 Mar 13.

3.

Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro.

Peng J, Wang Y, Zhang L, Zhao B, Zhao Z, Chen J, Guo Q, Liu S, Sui X, Xu W, Lu S.

Brain Res Bull. 2011 Feb 28;84(3):235-43. doi: 10.1016/j.brainresbull.2010.12.013. Epub 2010 Dec 29.

PMID:
21194558
4.

Herbal pre-conditioning induces proliferation and delays senescence in Wharton's Jelly Mesenchymal Stem Cells.

Sanap A, Chandravanshi B, Shah T, Tillu G, Dhanushkodi A, Bhonde R, Joshi K.

Biomed Pharmacother. 2017 Jul 15;93:772-778. doi: 10.1016/j.biopha.2017.06.107. [Epub ahead of print]

PMID:
28724259
5.

Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB.

PLoS One. 2010 Feb 2;5(2):e9016. doi: 10.1371/journal.pone.0009016.

6.

Lovastatin protects chondrocytes derived from Wharton's jelly of human cord against hydrogen-peroxide-induced in vitro injury.

Wajid N, Mehmood A, Bhatti FU, Khan SN, Riazuddin S.

Cell Tissue Res. 2013 Mar;351(3):433-43. doi: 10.1007/s00441-012-1540-3. Epub 2012 Dec 28.

PMID:
23271636
7.

Mitochondrial transfer from Wharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function.

Lin HY, Liou CW, Chen SD, Hsu TY, Chuang JH, Wang PW, Huang ST, Tiao MM, Chen JB, Lin TK, Chuang YC.

Mitochondrion. 2015 May;22:31-44. doi: 10.1016/j.mito.2015.02.006. Epub 2015 Mar 3.

PMID:
25746175
8.

Effect of serum choice on replicative senescence in mesenchymal stromal cells.

Liu Y, Li YQ, Wang HY, Li YJ, Liu GY, Xu X, Wu XB, Jing YG, Yao Y, Wu CT, Jin JD.

Cytotherapy. 2015 Jul;17(7):874-84. doi: 10.1016/j.jcyt.2015.02.012. Epub 2015 Mar 19.

PMID:
25800776
9.

Chronic Myeloid Leukemia Blood Inflicted Injury in Cord Derived Wharton's Jelly Mesenchymal Stem Cells.

Wajid N, Ali M, Javed S, Ali F, Anwar SS.

J Coll Physicians Surg Pak. 2016 May;26(5):361-5. doi: 2315.

PMID:
27225138
10.

The Effects of Indoxyl Sulfate on Human Umbilical Cord-Derived Mesenchymal Stem Cells In Vitro.

Wang W, Liu X, Wang W, Li J, Li Y, Li L, Wang S, Zhang J, Zhang Y, Huang H.

Cell Physiol Biochem. 2016;38(1):401-14. doi: 10.1159/000438639. Epub 2016 Jan 29.

11.

Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.

Xu Y, Huang S, Ma K, Fu X, Han W, Sheng Z.

J Tissue Eng Regen Med. 2012 Aug;6(8):645-54. doi: 10.1002/term.468. Epub 2011 Sep 13.

PMID:
21916019
12.

Oxidative stress-induced premature senescence in Wharton's jelly-derived mesenchymal stem cells.

Choo KB, Tai L, Hymavathee KS, Wong CY, Nguyen PN, Huang CJ, Cheong SK, Kamarul T.

Int J Med Sci. 2014 Sep 13;11(11):1201-7. doi: 10.7150/ijms.8356. eCollection 2014.

13.

Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.

Fong CY, Gauthaman K, Cheyyatraivendran S, Lin HD, Biswas A, Bongso A.

J Cell Biochem. 2012 Feb;113(2):658-68. doi: 10.1002/jcb.23395.

PMID:
21976004
14.

Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.

Zhang J, Chen GH, Wang YW, Zhao J, Duan HF, Liao LM, Zhang XZ, Chen YD, Chen H.

Chin Med J (Engl). 2012 Oct;125(19):3472-8.

PMID:
23044308
15.

Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.

Fang TC, Pang CY, Chiu SC, Ding DC, Tsai RK.

PLoS One. 2012;7(9):e46504. doi: 10.1371/journal.pone.0046504. Epub 2012 Sep 27.

16.

Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.

Schallmoser K, Bartmann C, Rohde E, Bork S, Guelly C, Obenauf AC, Reinisch A, Horn P, Ho AD, Strunk D, Wagner W.

Haematologica. 2010 Jun;95(6):867-74. doi: 10.3324/haematol.2009.011692. Epub 2010 Jan 6.

17.

Generating CK19-positive cells with hair-like structures from Wharton's jelly mesenchymal stromal cells.

Aljitawi OS, Xiao Y, Zhang D, Stehno-Bittel L, Garimella R, Hopkins RA, Detamore MS.

Stem Cells Dev. 2013 Jan 1;22(1):18-26. doi: 10.1089/scd.2012.0184. Epub 2012 Oct 19.

PMID:
22970796
18.

SIRT1 is required for long-term growth of human mesenchymal stem cells.

Yuan HF, Zhai C, Yan XL, Zhao DD, Wang JX, Zeng Q, Chen L, Nan X, He LJ, Li ST, Yue W, Pei XT.

J Mol Med (Berl). 2012 Apr;90(4):389-400. doi: 10.1007/s00109-011-0825-4. Epub 2011 Oct 27.

PMID:
22038097
19.

Restricted myogenic potential of mesenchymal stromal cells isolated from umbilical cord.

Grabowska I, Brzoska E, Gawrysiak A, Streminska W, Moraczewski J, Polanski Z, Hoser G, Kawiak J, Machaj EK, Pojda Z, Ciemerych MA.

Cell Transplant. 2012;21(8):1711-26. doi: 10.3727/096368912X640493. Epub 2012 Apr 17.

PMID:
22525423
20.

TGF-beta1 does not induce senescence of multipotent mesenchymal stromal cells and has similar effects in early and late passages.

Walenda G, Abnaof K, Joussen S, Meurer S, Smeets H, Rath B, Hoffmann K, Fröhlich H, Zenke M, Weiskirchen R, Wagner W.

PLoS One. 2013 Oct 17;8(10):e77656. doi: 10.1371/journal.pone.0077656. eCollection 2013.

Supplemental Content

Support Center